CureGN (Glomerulonephropathy)
A study of glomerular disease patients to better understand the causes of the disease, response to therapy, and disease progression.
A study of glomerular disease patients to better understand the causes of the disease, response to therapy, and disease progression.
To evaluate how the Medtronic 670G closed loop system impacts clinical and patient-reported outcomes in individuals with type 1 diabetes.
To better understand the effects of breastfeeding on infant growth and development.
To advance research on Minimal Change Disease (MCD), Focal and Segmental Glomerulosclerosis (FSGS), and Membranous Nephropathy (MN) that define nephrotic syndrome.
1. To identify family members of people with type 1 diabetes that may be at risk for developing type 1 diabetes. 2. To monitor the metabolic and immunologic status of at-risk individuals. Eligible individuals will be offered enrollment in type 1 diabetes prevention studies. See website for more details https://www.trialnet.org/
To better understand the effects of nutrition in early pregnancy on infant growth and development.